Skip to content

Documentation of Continuous Wheeze and Cough Dynamics in Pediatric ER SOB Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01414322
Enrollment
45
Registered
2011-08-11
Start date
2011-09-30
Completion date
2012-09-30
Last updated
2011-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Bronchiolitis

Brief summary

Phenotype characterization of shortness of breath of pediatric emergency room patients by objective wheeze and cough monitoring improves diagnostic and severity assessment accuracy and correlates with overall patient outcomes.

Interventions

None listed

Sponsors

Hadassah Medical Organization
CollaboratorOTHER
KarmelSonix Ltd.
Lead SponsorINDUSTRY

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 15 Years
Healthy volunteers
No

Inclusion criteria

* patient is admitted to the ER with shortness of breath * patient management is according to standardized protocols used in Hadassah Mt. Scopus pediatric emergency department including: * asthma management protocol * bronchiolitis management protocol * ages 0 - 15 * patient's parent/guardian is able to comprehend and give informed consent for participating in the study

Exclusion criteria

* patient has received any dose of inhaled bronchodilators in the hour prior to enrollment * patient has received oral or IV steroids in a time window of 30 minutes to 5 hours prior to enrollment * ventilated patients, while ventilated * chest skin lesions * cystic fibrosis * hemodynamic instability * patient's parent/guardian objects to the study protocol * concurrent participation in any other clinical study * physician objection

Design outcomes

Primary

MeasureTime frameDescription
increase or decrease of WheezeRate (the proportion of wheezing in the respiratory cycle)Duration (from beginning to end) of emergency department stay. On average, 3 hours.Characterize the dynamic pattern of wheeze rate (increase or decrease by 50% or unchanged) within 30 minutes of onset of therapy, and to correlate pattern to clinical diagnoses, severity assessment (accessory muscle use, oxygen saturation, inspiratory/expiratory ratio, severity of wheezing), and outcome (admission versus discharge).

Secondary

MeasureTime frameDescription
cough count (increase or decrease by more then 1 cough event or unchanged) in response to treatmentDuration (from beginning to end) of emergency department stay. On average, 3 hours.cough count (increase or decrease by more then 1 cough event or unchanged) in response to treatment and to correlate pattern to clinical diagnoses, severity assessment (accessory muscle use, oxygen saturation, inspiratory/expiratory ratio, severity of wheezing), and outcome (admission versus discharge).

Countries

Israel

Contacts

Primary ContactNoam Gavriely, MD PhD
noam@karmelsonix.com+972 54 466 1337
Backup ContactEzekiel Balouka, MSc
ezekiel@karmelsonix.com+972 52 312 1098

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026